UPDATE: Covidien closes oxygen therapy sale to Chart Industries

September 3, 2009 by MassDevice staff

Covidien closes deals to sell its oxygen therapy line to Chart Industries Inc. and its sleep diagnotics line to Embla for undisclosed amounts.

Covidien closes oxygen therapy sale to Chart Industries

Covidien (NYSE: COV) closed the deal to sell its oxygen therapy line to Chart Industries Inc. for an undisclosed amount, part of its move to streamline operations and focus on faster-growing, higher-margin businesses.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp